Pacitti David bought 20,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 for $100k on Nov 9, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 9, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$100,000Shares × reported price
Shares traded
20,000Common Stock, par value $0.0001 per share
Price per share
$5.00Reported price. Read footnotes for ranges.
% of reported position traded
36.53%This security and ownership context
Holdings after
74,750Direct
Trade date
Nov 9, 2026Buy
Filed
Nov 9, 2026, 4:31 PM ET0-day reporting delay
Accession
0001104659-26-124537Code P · Transaction 396028
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 54,750 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

OBIO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
OBIO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +4.4%1w ago +3.7%1d ago −0.4%
Returns since7d30d90d180d1y

Footnotes in full

F1: These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share.